Answers are grounded in this paper and cite their sources.
Scoping review demonstrates efficacy of topical imiquimod in reducing lesions in oral cavity dysplasia, suggesting a new treatment avenue.
Topical imiquimod for the treatment of oral cavity leukoplakia and dysplasia is a promising new treatment strategy. Efficacy has been demonstrated in reducing lesion size and even complete lesion resolution, with minimal adverse effects. Further research is needed on this innovative therapeutic approach.
No takes yet. Share an insight, caveat, or question.
Scharner et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: